Herbal extract RM01 and its use and preparation method
The herbal extract RM01, composed of Ophiopogon, wolfberry, and Codonopsis serrata, addresses the limitations of current Alzheimer's treatments by improving cognitive function and reducing β-amyloid plaques, offering a promising therapeutic option for Alzheimer's disease.
Patent Information
- Application Number
- JP2025541879
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-09-27
- Filing Date
- 2023-09-26
- Publication Date
- 2025-09-19
AI Technical Summary
Current treatments for Alzheimer's disease only slow its progression without halting it, and there is a need for effective therapies to prevent and ameliorate its symptoms, particularly for individuals with mild cognitive impairment and varying stages of Alzheimer's disease.
An herbal extract composition, RM01, comprising a mixture of Ophiopogon, wolfberry, Datura stramonium, and Codonopsis serrata, is administered orally to individuals, prepared by heating the mixture in water for 30-60 minutes to collect a liquid extract, which is then used to treat neurodegenerative diseases like Alzheimer's disease.
The herbal extract composition RM01 shows potential in improving cognitive function and memory, reducing β-amyloid plaques, and increasing MMSE scores in individuals with Alzheimer's disease, potentially outperforming existing drugs in alleviating symptoms and slowing disease progression.
Smart Images
Figure 2025531588000001_ABST